Cargando…
Magnesium Supplement and the 15q11.2 BP1–BP2 Microdeletion (Burnside–Butler) Syndrome: A Potential Treatment?
The 15q11.2 BP1–BP2 microdeletion (Burnside–Butler) syndrome is an emerging disorder that encompasses four genes (NIPA1, NIPA2, CYFIP1, and TUBGCP5). When disturbed, these four genes can lead to cognitive impairment, language and/or motor delay, psychiatric/behavioral problems (attention-deficit hyp...
Autor principal: | Butler, Merlin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627575/ https://www.ncbi.nlm.nih.gov/pubmed/31207912 http://dx.doi.org/10.3390/ijms20122914 |
Ejemplares similares
-
Parent-of-Origin Effects in 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome
por: Davis, Kyle W., et al.
Publicado: (2019) -
The 15q11.2 BP1-BP2 Microdeletion (Burnside–Butler) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Disorders
por: Rafi, Syed K., et al.
Publicado: (2020) -
Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families
por: Baldwin, Isaac, et al.
Publicado: (2021) -
Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature
por: Farrell, Martilias, et al.
Publicado: (2020) -
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
por: Cox, Devin M., et al.
Publicado: (2015)